PotlatchDeltic (PCH) Competitors $38.95 -0.34 (-0.87%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$38.65 -0.30 (-0.76%) As of 04/11/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCH vs. OHI, CUBE, HR, RHP, SBRA, GEO, RYN, EPR, NHI, and MPWShould you be buying PotlatchDeltic stock or one of its competitors? The main competitors of PotlatchDeltic include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), Sabra Health Care REIT (SBRA), The GEO Group (GEO), Rayonier (RYN), EPR Properties (EPR), National Health Investors (NHI), and Medical Properties Trust (MPW). These companies are all part of the "specialized reits" industry. PotlatchDeltic vs. Omega Healthcare Investors CubeSmart Healthcare Realty Trust Ryman Hospitality Properties Sabra Health Care REIT The GEO Group Rayonier EPR Properties National Health Investors Medical Properties Trust PotlatchDeltic (NASDAQ:PCH) and Omega Healthcare Investors (NYSE:OHI) are both construction companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking. Is PCH or OHI a better dividend stock? PotlatchDeltic pays an annual dividend of $1.80 per share and has a dividend yield of 4.6%. Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.1%. PotlatchDeltic pays out 642.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Omega Healthcare Investors pays out 172.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Omega Healthcare Investors is clearly the better dividend stock, given its higher yield and lower payout ratio. Is PCH or OHI more profitable? Omega Healthcare Investors has a net margin of 38.65% compared to PotlatchDeltic's net margin of 2.06%. Omega Healthcare Investors' return on equity of 9.71% beat PotlatchDeltic's return on equity.Company Net Margins Return on Equity Return on Assets PotlatchDeltic2.06% 1.05% 0.65% Omega Healthcare Investors 38.65%9.71%4.35% Do institutionals & insiders hold more shares of PCH or OHI? 86.1% of PotlatchDeltic shares are owned by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are owned by institutional investors. 2.0% of PotlatchDeltic shares are owned by insiders. Comparatively, 1.4% of Omega Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer PCH or OHI? In the previous week, Omega Healthcare Investors had 6 more articles in the media than PotlatchDeltic. MarketBeat recorded 15 mentions for Omega Healthcare Investors and 9 mentions for PotlatchDeltic. Omega Healthcare Investors' average media sentiment score of 1.24 beat PotlatchDeltic's score of 1.12 indicating that Omega Healthcare Investors is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PotlatchDeltic 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Omega Healthcare Investors 11 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, PCH or OHI? PotlatchDeltic has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Omega Healthcare Investors has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Does the MarketBeat Community favor PCH or OHI? Omega Healthcare Investors received 159 more outperform votes than PotlatchDeltic when rated by MarketBeat users. Likewise, 57.70% of users gave Omega Healthcare Investors an outperform vote while only 52.76% of users gave PotlatchDeltic an outperform vote. CompanyUnderperformOutperformPotlatchDelticOutperform Votes28752.76% Underperform Votes25747.24% Omega Healthcare InvestorsOutperform Votes44657.70% Underperform Votes32742.30% Do analysts prefer PCH or OHI? PotlatchDeltic presently has a consensus target price of $48.71, indicating a potential upside of 25.07%. Omega Healthcare Investors has a consensus target price of $42.00, indicating a potential upside of 10.99%. Given PotlatchDeltic's stronger consensus rating and higher possible upside, analysts clearly believe PotlatchDeltic is more favorable than Omega Healthcare Investors.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PotlatchDeltic 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Omega Healthcare Investors 0 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has better valuation and earnings, PCH or OHI? Omega Healthcare Investors has lower revenue, but higher earnings than PotlatchDeltic. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than PotlatchDeltic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPotlatchDeltic$1.06B2.89$21.88M$0.28139.11Omega Healthcare Investors$1.05B10.14$406.33M$1.5524.41 SummaryOmega Healthcare Investors beats PotlatchDeltic on 12 of the 20 factors compared between the two stocks. Remove Ads Get PotlatchDeltic News Delivered to You Automatically Sign up to receive the latest news and ratings for PCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCH vs. The Competition Export to ExcelMetricPotlatchDelticReal estate investment trusts IndustryConstruction SectorNASDAQ ExchangeMarket Cap$3.07B$6.53B$7.84B$7.52BDividend Yield4.71%7.16%2.08%4.30%P/E Ratio139.1155.7615.0317.69Price / Sales2.896.3671.5893.44Price / Cash24.5617.3221.4034.64Price / Book1.511.573.953.89Net Income$21.88M$177.71M$535.55M$247.17M7 Day Performance-3.54%-3.51%60.49%1.77%1 Month Performance-11.50%-10.45%54.43%-8.64%1 Year Performance-11.30%-0.69%70.59%-4.07% PotlatchDeltic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCHPotlatchDeltic4.3192 of 5 stars$38.95-0.9%$48.71+25.1%N/A$3.07B$1.06B139.111,330News CoveragePositive NewsOHIOmega Healthcare Investors3.5568 of 5 stars$36.26-2.9%$42.00+15.8%N/A$10.22B$1.05B23.3950Options VolumeNews CoveragePositive NewsCUBECubeSmart4.0808 of 5 stars$37.45-5.3%$48.00+28.2%N/A$8.53B$1.07B21.162,800Analyst UpgradeNews CoverageHRHealthcare Realty Trust3.6788 of 5 stars$15.33-4.9%$17.00+10.9%N/A$5.38B$1.25B-8.61580News CoveragePositive NewsHigh Trading VolumeRHPRyman Hospitality Properties3.9119 of 5 stars$81.17-4.1%$124.67+53.6%N/A$4.86B$2.34B18.491,270Analyst ForecastNews CoveragePositive NewsHigh Trading VolumeSBRASabra Health Care REIT2.1095 of 5 stars$16.47-4.7%$19.33+17.4%N/A$3.92B$703.24M31.0840News CoveragePositive NewsGEOThe GEO Group3.0811 of 5 stars$27.45+1.6%$41.00+49.4%N/A$3.87B$2.42B94.6415,800Positive NewsRYNRayonier4.1651 of 5 stars$24.20-3.4%$29.00+19.8%N/A$3.78B$1.26B10.25420News CoveragePositive NewsHigh Trading VolumeEPREPR Properties3.7904 of 5 stars$45.49-2.9%$51.00+12.1%N/A$3.46B$641.00M19.6960News CoverageHigh Trading VolumeNHINational Health Investors3.3587 of 5 stars$69.35-2.9%$85.50+23.3%N/A$3.17B$335.18M23.8320News CoverageMPWMedical Properties Trust2.812 of 5 stars$5.17-1.4%$5.64+9.3%N/A$3.10B$995.55M-1.22120Positive News Remove Ads Related Companies and Tools Related Companies Omega Healthcare Investors Competitors CubeSmart Competitors Healthcare Realty Trust Competitors Ryman Hospitality Properties Competitors Sabra Health Care REIT Competitors The GEO Group Competitors Rayonier Competitors EPR Properties Competitors National Health Investors Competitors Medical Properties Trust Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCH) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PotlatchDeltic Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PotlatchDeltic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.